Dolutegravir-based Antiretroviral Therapy for Patients Coinfected with Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

Kelly E. Dooley, Richard Kaplan, Noluthando Mwelase, Beatriz Grinsztejn, Eduardo Ticona, Marcus Lacerda, Omar Sued, Elena Belonosova, Mounir Ait-Khaled, Konstantinos Angelis, Dannae Brown, Rajendra Singh, Christine L. Talarico, Allan R. Tenorio, Michael R. Keegan, Michael Aboud, Kelly E. Dooley, Kaplan Richard, Mwelase Noluthando, Grinsztejn BeatrizTicona Chavez Eduardo, Lacerda Marcus, Sued Omar, Belonosova Elena, Ait Khaled Mounir, Angelis Konstantinos, Brown Dannae, Singh Rajendra, Christine L. Talarico, Allan R. Tenorio, Michael R. Keegan, Aboud Michael, Lupo Sergio, Cahn Pedro, Porteiro Norma, Daniel Lopardo Gustavo, Riegel Santos Breno, Madruga Jose, Roberto Alves Carlos, Patricia Quintero Perez Nora, Rodriguez Noriega Eduardo, Perez Rios Alma, Perez Patrigeon Santiago, Mosqueda Gómez Juan-Luis, Paredes Paredes Mercedes, Rodriguez Aldo, Mac Rae John, Casapia Wilfredo, Sanchez Vergaray Eduardo, Belonosova Elena, Sultanov Lenar, Ivanova Elvira, Yakovlev Alexey, Panteleev Alexander, Dawson Rodney, Latiff Gulam, Mohapi Lerato, Taljaard Jantjie, Jurgens Lombaard Johannes, Khan Mohammed, Variava Ebrahim, Chetchotisakd Ploenchan, Kiertiburanakul Sasisopin, Avihingsanon Anchalee

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Dolutegravir-based Antiretroviral Therapy for Patients Coinfected with Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences